All Articles

A Texas law requires bounce house vendors to be insured and inspected, but many operators ignore it. Here’s the two-minute check you’re not doing.

In its first full quarter as an AI company, Corvex reports a major loss but reveals a $22M contract pipeline. Is this a savvy pivot or a costly bet?

LEDVANCE's latest innovations, recognized by industry experts, aren't just brighter bulbs. They are systemic tools for safety and efficiency in extreme environments.

The EOR giant renewed its SOC 2 Type II, but the real story is how its layered security strategy redefines trust and operational resilience in global HR.

Once a billion-dollar star, Goodfood Market Corp. now seeks a savior in a court-approved sale. A deep dive into the financial collapse and what comes next.

From AI security to quantum navigation, VetsinTech's latest finalists reveal a powerful trend: veteran founders are building tomorrow's critical infrastructure.

On the 14th anniversary of his abduction in Syria, the call to free Austin Tice grows louder, yet the journalist and veteran remains missing.

In a swift 24-hour strike, New York Teamsters secured a landmark deal with a beverage giant, winning not just wages but a crucial foothold against AI.

Vietnam's Viettel Group dominated the 2026 International Business Awards, a stunning victory that confirms its successful pivot from telecom to tech powerhouse.

GMO Internet Group's elite hackers conquered the 'Olympics of Hacking.' We explore how this hard-won victory impacts real-world security and the future of AI-driven cyber warfare.

With billions on the line and major projects moving forward, Canada's CCUS sector is at a crossroads. A pivotal conference in Edmonton will test if policy can fuel profit.

A new coaster and resort are just the start. We dissect how a $150M investment in Ozarks heritage aims to transform a theme park into a national destination.

A beloved brand returns to Maryland’s billion-dollar cannabis market. But is this a story of community or a calculated play for market share?

In a strategic pivot, Skye Bioscience acquires Redx Pharma, creating Fibrx Therapeutics—a new Nasdaq-listed player armed with $125M and a bold plan.

With assets soaring 290% and revenue nearly doubling, PMGC Holdings' pivot to strategic acquisitions in aerospace and tech is paying off spectacularly.

How the Royal Canadian Mint's diversified model, blending global coin contracts with savvy metals trading, is delivering resilience and profit in a volatile Q2.

The Detroit Lions' new VR deal isn't just about cool tech; it's a bold play to rewrite the rules of fan access and sports media rights forever.

Reading International posts record post-pandemic profits, fueled by a stellar film slate. But beneath the surface, a surge in short-term debt reveals a high-stakes balancing act.

Shedding its IT baggage, Vaso Corp's Q2 results reveal a focused, profitable healthcare strategy. Is this the new blueprint for MedTech success?

New preclinical data shows NurExone's ExoPTEN protects vital nerve coatings, providing a biological basis for functional recovery in spinal cord injury models.